- Rongsheng Petro reported a net income of 602.1 million yuan for the first half of the year.
- The earnings per share (EPS) for this period stood at 6.0 RMB cents.
- The investment outlook is positive with analysts showing strong confidence, given 14 buy recommendations.
- There are 2 hold recommendations for Rongsheng Petro stocks, indicating some cautious optimism.
- Notably, there are no sell recommendations, reflecting a lack of negative sentiment among analysts.
A look at Rongsheng Petro Chemical A Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 3 | |
| Growth | 2 | |
| Resilience | 2 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have assessed Rongsheng Petro Chemical A using their proprietary Smart Scores, which rate companies on various factors affecting their long-term outlook. Rongsheng Petro Chemical A received a strong score in the Value category, indicating that the company may be undervalued compared to its peers. However, its scores for Dividend, Growth, Resilience, and Momentum were slightly lower, suggesting areas where the company may need to focus on improving for long-term sustainability.
Rongsheng Petro Chemical Company Limited specializes in manufacturing and selling purified terephthalic acid (PTA) and various polyester yarn products. Despite its high Value score, analysts point out potential areas for growth and resilience improvement based on its Smart Scores in Dividend, Growth, Resilience, and Momentum. Investors may want to keep an eye on how the company addresses these factors to ensure a more balanced long-term outlook.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
